Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial compared different ways of having rituximab alongside chemotherapy as the first treatment for diffuse large B cell lymphoma.
It was open for people to join between 2012 and 2016, and the research team published the results in 2017.
Recruitment start: 22 August 2012
Recruitment end: 18 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Andrew Hodson
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 28 September 2020
CRUK internal database number: 10669